StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences indoor water use (legacy breakout, ML)

Gilead 2023 ESG Impact Report

Latest, FY2022
702
Period ended Dec 31, 2022
Change on a year earlier
+0.7%
697 in FY2021
History
4 years
Since FY2019
Sources
1
Gilead Sustainability / IR (2023-environmental-social-governance-impact-report.pdf)

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Gilead Sciences Indoor water use (legacy breakout, ML), annual FY2019–FY2022 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/esg_water_indoor

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.